Key Market Indicators
Sales of antidepressant medication in South Korea are projected to climb to approximately $364 million by 2028, up from $302 million in 2023. This represents an average annual growth rate of 3%. Since 2013, the Korean market for antidepressants has experienced an average annual increase of 9.1%. In 2023, South Korea ranked fifth globally in this sector. Australia surpassed South Korea in 2023, with sales also reaching $302 million. Spain, Italy, and Australia held the second, third, and fourth spots, respectively, in the global rankings for antidepressant medication sales.
